Kura Oncology IncNASDAQ:KURA
- LAST PRICE10.8100
- TODAY'S CHANGE (%)-0.4900 (-4.3363%)
- Bid / Lots10.7500/ 1
- Ask / Lots11.3100/ 10
- Open / Previous Close11.2700 / 11.3000
- Day Range
- 52 Week Range
- Volume1,362,181
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KURA |
|---|---|---|
| 09:32 ET | 6539 | 11.25 |
| 09:33 ET | 3452 | 11.13 |
| 09:35 ET | 3312 | 11.165 |
| 09:37 ET | 816 | 11.185 |
| 09:39 ET | 1100 | 11.11 |
| 09:42 ET | 1244 | 11.11 |
| 09:44 ET | 501 | 11.15 |
| 09:46 ET | 7071 | 11.15 |
| 09:48 ET | 4490 | 11.21 |
| 09:50 ET | 3101 | 11.23 |
| 09:51 ET | 2144 | 11.22 |
| 09:53 ET | 200 | 11.185 |
| 09:55 ET | 700 | 11.21 |
| 09:57 ET | 2850 | 11.17 |
| 10:00 ET | 371 | 11.145 |
| 10:02 ET | 2894 | 11.225 |
| 10:04 ET | 2324 | 11.248 |
| 10:06 ET | 1702 | 11.31 |
| 10:08 ET | 1215 | 11.32 |
| 10:09 ET | 558 | 11.3999 |
| 10:11 ET | 1371 | 11.33 |
| 10:13 ET | 1284 | 11.34 |
| 10:15 ET | 1518 | 11.32 |
| 10:18 ET | 1982 | 11.31 |
| 10:20 ET | 2003 | 11.35 |
| 10:22 ET | 3450 | 11.3 |
| 10:24 ET | 204 | 11.33 |
| 10:26 ET | 1931 | 11.32 |
| 10:27 ET | 871 | 11.3 |
| 10:29 ET | 2532 | 11.29 |
| 10:31 ET | 2469 | 11.31 |
| 10:33 ET | 928 | 11.36 |
| 10:36 ET | 2810 | 11.3 |
| 10:38 ET | 2386 | 11.24 |
| 10:40 ET | 1670 | 11.19 |
| 10:42 ET | 1704 | 11.19 |
| 10:44 ET | 2603 | 11.24 |
| 10:45 ET | 3328 | 11.26 |
| 10:47 ET | 820 | 11.28 |
| 10:49 ET | 1803 | 11.25 |
| 10:51 ET | 803 | 11.24 |
| 10:54 ET | 4790 | 11.19 |
| 10:56 ET | 1100 | 11.19 |
| 10:58 ET | 3117 | 11.18 |
| 11:00 ET | 1501 | 11.19 |
| 11:02 ET | 5756 | 11.23 |
| 11:03 ET | 200 | 11.2252 |
| 11:05 ET | 5786 | 11.225 |
| 11:07 ET | 2497 | 11.24 |
| 11:09 ET | 9459 | 11.21 |
| 11:12 ET | 2385 | 11.22 |
| 11:14 ET | 8113 | 11.19 |
| 11:16 ET | 1903 | 11.185 |
| 11:18 ET | 1273 | 11.175 |
| 11:20 ET | 9566 | 11.13 |
| 11:21 ET | 3051 | 11.155 |
| 11:23 ET | 3425 | 11.09 |
| 11:25 ET | 5536 | 11.03 |
| 11:27 ET | 4920 | 11 |
| 11:30 ET | 4088 | 10.93 |
| 11:32 ET | 9044 | 11.03 |
| 11:34 ET | 3123 | 10.97 |
| 11:36 ET | 100 | 10.975 |
| 11:38 ET | 2351 | 10.94 |
| 11:39 ET | 15200 | 10.86 |
| 11:41 ET | 1875 | 10.82 |
| 11:43 ET | 200 | 10.84 |
| 11:45 ET | 3142 | 10.88 |
| 11:48 ET | 991 | 10.86 |
| 11:50 ET | 3324 | 10.8 |
| 11:52 ET | 2692 | 10.76 |
| 11:54 ET | 5438 | 10.73 |
| 11:56 ET | 2990 | 10.8021 |
| 11:57 ET | 1002 | 10.84 |
| 11:59 ET | 2200 | 10.81 |
| 12:01 ET | 3556 | 10.81 |
| 12:03 ET | 700 | 10.8 |
| 12:06 ET | 52942 | 10.72 |
| 12:08 ET | 3185 | 10.725 |
| 12:10 ET | 2114 | 10.685 |
| 12:12 ET | 3371 | 10.61 |
| 12:14 ET | 1207 | 10.61 |
| 12:15 ET | 900 | 10.59 |
| 12:17 ET | 2921 | 10.6 |
| 12:19 ET | 4381 | 10.605 |
| 12:21 ET | 7873 | 10.615 |
| 12:24 ET | 8253 | 10.58 |
| 12:26 ET | 14187 | 10.55 |
| 12:28 ET | 13423 | 10.485 |
| 12:30 ET | 5543 | 10.51 |
| 12:32 ET | 5396 | 10.475 |
| 12:33 ET | 1844 | 10.48 |
| 12:35 ET | 2979 | 10.497 |
| 12:37 ET | 4201 | 10.65 |
| 12:39 ET | 1694 | 10.645 |
| 12:42 ET | 3452 | 10.63 |
| 12:44 ET | 1745 | 10.6284 |
| 12:46 ET | 2373 | 10.61 |
| 12:48 ET | 4913 | 10.6 |
| 12:50 ET | 1288 | 10.54 |
| 12:51 ET | 3006 | 10.585 |
| 12:53 ET | 774 | 10.57 |
| 12:55 ET | 2449 | 10.58 |
| 12:57 ET | 3934 | 10.63 |
| 01:00 ET | 2167 | 10.61 |
| 01:02 ET | 809 | 10.6 |
| 01:04 ET | 3880 | 10.56 |
| 01:06 ET | 3001 | 10.6 |
| 01:08 ET | 2297 | 10.59 |
| 01:09 ET | 8630 | 10.591 |
| 01:11 ET | 3992 | 10.56 |
| 01:15 ET | 4223 | 10.55 |
| 01:18 ET | 6882 | 10.53 |
| 01:20 ET | 2071 | 10.56 |
| 01:22 ET | 2204 | 10.6 |
| 01:24 ET | 2614 | 10.62 |
| 01:26 ET | 3834 | 10.605 |
| 01:27 ET | 700 | 10.61 |
| 01:29 ET | 3134 | 10.68 |
| 01:31 ET | 1526 | 10.63 |
| 01:33 ET | 1300 | 10.66 |
| 01:36 ET | 2459 | 10.64 |
| 01:38 ET | 1301 | 10.71 |
| 01:40 ET | 1437 | 10.71 |
| 01:42 ET | 27798 | 10.535 |
| 01:44 ET | 500 | 10.52 |
| 01:45 ET | 4654 | 10.54 |
| 01:47 ET | 691 | 10.545 |
| 01:49 ET | 6712 | 10.4 |
| 01:51 ET | 1565 | 10.41 |
| 01:54 ET | 4130 | 10.53 |
| 01:56 ET | 3504 | 10.54 |
| 01:58 ET | 403 | 10.52 |
| 02:00 ET | 3322 | 10.505 |
| 02:02 ET | 1348 | 10.45 |
| 02:03 ET | 1200 | 10.43 |
| 02:05 ET | 3280 | 10.51 |
| 02:07 ET | 1200 | 10.51 |
| 02:09 ET | 3768 | 10.49 |
| 02:12 ET | 300 | 10.52 |
| 02:14 ET | 400 | 10.49 |
| 02:16 ET | 29138 | 10.515 |
| 02:18 ET | 1446 | 10.49 |
| 02:20 ET | 3343 | 10.51 |
| 02:21 ET | 1424 | 10.515 |
| 02:23 ET | 2023 | 10.6 |
| 02:25 ET | 2220 | 10.5827 |
| 02:27 ET | 4593 | 10.665 |
| 02:30 ET | 2171 | 10.73 |
| 02:32 ET | 1989 | 10.76 |
| 02:34 ET | 4915 | 10.73 |
| 02:36 ET | 400 | 10.73 |
| 02:38 ET | 2189 | 10.79 |
| 02:39 ET | 407 | 10.81 |
| 02:41 ET | 849 | 10.82 |
| 02:43 ET | 4439 | 10.83 |
| 02:45 ET | 2293 | 10.84 |
| 02:48 ET | 2602 | 10.85 |
| 02:50 ET | 2486 | 10.87 |
| 02:52 ET | 2240 | 10.87 |
| 02:54 ET | 3977 | 10.87 |
| 02:56 ET | 2371 | 10.88 |
| 02:57 ET | 1466 | 10.86 |
| 02:59 ET | 1656 | 10.88 |
| 03:01 ET | 2680 | 10.89 |
| 03:03 ET | 1600 | 10.905 |
| 03:06 ET | 2856 | 10.86 |
| 03:08 ET | 1263 | 10.87 |
| 03:10 ET | 3429 | 10.92 |
| 03:12 ET | 980 | 10.91 |
| 03:14 ET | 1103 | 10.93 |
| 03:15 ET | 1371 | 10.93 |
| 03:17 ET | 500 | 10.93 |
| 03:19 ET | 3867 | 10.86 |
| 03:21 ET | 4213 | 10.845 |
| 03:24 ET | 2074 | 10.85 |
| 03:26 ET | 4135 | 10.88 |
| 03:28 ET | 2044 | 10.87 |
| 03:30 ET | 2638 | 10.88 |
| 03:32 ET | 1733 | 10.88 |
| 03:33 ET | 4763 | 10.855 |
| 03:35 ET | 4249 | 10.88 |
| 03:37 ET | 5601 | 10.845 |
| 03:39 ET | 2294 | 10.85 |
| 03:42 ET | 4959 | 10.86 |
| 03:44 ET | 4402 | 10.84 |
| 03:46 ET | 3772 | 10.85 |
| 03:48 ET | 4903 | 10.8669 |
| 03:50 ET | 5955 | 10.85 |
| 03:51 ET | 8222 | 10.85 |
| 03:53 ET | 11124 | 10.81 |
| 03:55 ET | 12646 | 10.82 |
| 03:57 ET | 22360 | 10.81 |
| 04:00 ET | 33861 | 10.81 |
Yesterday
DJ Kura Oncology Price Target Maintained With a $32.00/Share by HC Wainwright & Co., from 20 hours ago by Dow Jones
20 hours ago by Dow JonesKura Oncology's Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society's Pediatric Acute Leukemia (PedAL) Master Clinical Trial, from 23 hours ago by Dow Jones
23 hours ago by Dow Jones
Nov 28, 2023
Kura Oncology to Participate in the JMP Securities Hematology and Oncology Summit, from 7:30AM ET on Tuesday Nov 28, 2023 by Dow Jones
7:30AM ET on Tuesday Nov 28, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kura Oncology Inc | 802.9M | -5.4x | --- |
Prime Medicine Inc | 827.3M | -4.6x | --- |
Northwest Biotherapeutics Inc | 843.6M | -10.9x | --- |
89Bio Inc | 745.8M | -4.9x | --- |
Cogent Biosciences Inc | 744.1M | -3.7x | --- |
Sana Biotechnology Inc | 733.3M | -2.6x | --- |
Company Information
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of medicines for the treatment of cancer. The Company’s pipeline consists of small molecule product candidates that target cancer signaling pathways. The Company’s products candidate includes Ziftomenib, Tipifarnib, and KO-2806. The Ziftomenib is a potent, selective, reversible and oral small molecule inhibitor that blocks the interaction of two proteins, menin and the protein expressed by the Lysine K-specific Methyl Transferase 2A gene for the treatment of genetically defined acute myeloid leukemia (AML) patients. Tipifarnib is a potent, selective and orally bioavailable inhibitor of farnesyl transferase. KO-2806, is a next generation farnesyl transferase inhibitor (FTI), which it demonstrates improved potency, pharmacokinetic and physicochemical properties relative to earlier FTI drug candidates.
Contact Information
- Headquarters
- 12730 HIGH BLUFF DRIVE, SUITE 400SAN DIEGO, CA, United States 92130
- Phone
- 858-500-8800
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Troy Wilson
- Chief Operating Officer
- Kathleen Ford
- Chief Medical Officer
- Stephen Dale
- Chief Commercial Officer
- Brian Powl
- Chief Legal Officer, Secretary
- Teresa Bair
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $802.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 74.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-2.02 |
Book Value | $6.15 |
P/E Ratio | -5.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
